SimBioSys, Inc. — Form D
SimBioSys, Inc. of CHICAGO, IL, a company, filed a Form D exempt-offering notice with the SEC on 2025-01-06. The offering totals $8.0M, of which $5.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-01-06
- Form: D
- Accession: 0001759213-25-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $8.0M
- Amount sold: $5.2M
- Remaining: $2.8M
- Investors: 13
- Date of first sale: 2024-12-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-534239
Issuer
- Name: SimBioSys, Inc.
- CIK: 0001759213
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 320 N. SANGAMON STREET, 7TH FLOOR, CHICAGO, IL, 60607
- Phone: 872-365-3112
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Ronnie Andrews | Director | Chicago, IL |
| Vikram Chaudhery | Director | Chicago, IL |
| Lucy Coassin | Director | MENLO PARK, CA |
| William Hyun | Director | Chicago, IL |
| Joseph Peterson | Director | Chicago, IL |
| Stacey Stevens | Director | Chicago, IL |
| Joseph Peterson | Executive Officer | Chicago, IL |
| Stacey Stevens | Executive Officer | Chicago, IL |
| John A Cole | Executive Officer | Champaign, IL |
| Joseph R Peterson | Executive Officer | Champaign, IL |
Other filings by this issuer (1)
More